Summary
Patients suffering from chronic obstructive airway disease often have arterial hypoxemia, which is more or less severe. If hypoxemia deteriorates the function of the liver is still unknown. The aim of this study was to determine, if a mostly oxygen dependent process of liver metabolism (galactose elimination capacity) is disturbed and if it can be increased by oxygen insufflation. Under the same conditions an oxygen independent process (indocyaninegreen clearance) should not be influenced. Our results show, that galactose elimination capacity under room air was pathologic and can be increased significantly by oxygen breathing. No change of indocyaninegreen clearance was seen under the same conditions. After termination of oxygen therapy the galactose elimination capacity was as bad as before oxygen breathing. Dysfunctions of the liver, which are caused by hypoxemia, can be positively influenced by oxygen, but only for the duration of oxygen insufflation.
Similar content being viewed by others
Abbreviations
- Adm:
-
Mitteldruck im rechten Vorhof
- CHE:
-
Cholinesterase
- Gamma-GT:
-
Gamma-Glutamyl-Transferase
- GEK:
-
Galaktose-Eliminations-Kapazität
- ICG-HWZ:
-
Indocyaningrün-Halbwertzeit
- KG:
-
Körpergewicht
- NAD:
-
Nicotinsäureamid
- NADH2 :
-
reduziertes Nicotinsäureamid
- O2 :
-
molekularer Sauerstoff
- pCO2a :
-
arterieller Kohlensäurepartialdruck
- pO2a :
-
arterieller Sauerstoffpartialdruck
- SGOT:
-
Serum-Glutamat-Oxalacetat-Transaminase
- SGPT:
-
Serum-Glutamat-Pyruvat-Transaminase
- SO2a :
-
arterielle Sauerstoffsättigung
Literatur
Bär U, Schroeter U, Schmidt FW (1970) A combined liver function test with bromsulfalein, indocyanine green and galactose. Eur J clin Invest 1:125–126
Caesar J, Shaldon S, Chiandussi L (1961) The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 21:43–57
Cooke AR, Harrison DD, Skyring AP (1963) Use of indocyanine green as a test of liver function. Amer J dig Dis 8:244–250
Forsander OA (1966) The galactose tolerance test as a measurement of the redox potential of the liver. Scand J clin Lab Invest 18:143–144
Fox LJ, Brooker LGS, Heseltine DW (1957) A tricarbocyanine dye for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Mayo Clin Proc 32:478–484
Henning R, Knodel W (1969) Die intravenöse Galaktose-Belastung. Enzymatische Substratbestimmung im Kapillarblut. Med Welt 20:7–9
Hunton DP, Bollman JL, Hoffman HN (1960) Studies of hepatic function with indocyanine green. Gastroenterology 39:713–724
Isselbacher KJ, Krane SM (1959) Studies on the mechanism of the inhibition of galactose oxydation by ethanol. J Bio Chem 236:2394–2398
Kuntz HD, May B (1983) Veränderungen der Leberfunktion bei Schockleber und akuter Stauungsleber. Intensivmed 20:17–20
Kuntz HD, Matthes U, Reitemeyer E, Tönissen R, May B (1987) Leber und Herz. Med Welt 38:1410–1415
Leevy CM, Mendenhall CL, Lesko W, Howard MM (1962) Estimation of hepatic blood flow with indocyanine green. J clin Invest 41:1169–1179
Leevy CM, Bendorf J, Silverberg M, Naylor J (1963) Physiology of dye extraction by the liver: comparative studies of sulfobromophthalin and indocyanine green. Ann N Y Acad Sci 111:161–175
Leevy CM, Smith F, Longueville J (1977) Indocyanine green clearance as a test for hepatic function. J Amer med Ass 200:236–240
Leevy CM, Leevy CB, Howard MM (1979) Indocyanine green and the liver. In: Davidson CS (ed) Problems in liver diseases. Thieme, Stuttgart New York, pp 42–52
Liehr H (1982) Die Bedeutung der Leber und des RES im Schock. Hämostaseologie 2:68–72
Nilsson LH, Hultman E (1974) A comparison of the bromsulphthalein and galactose elimination test in patients either with chronic bowel inflammation or alcoholic liver disease. Scand J Gastroent 9:319–323
Paumgartner G (1975) The handling of indocyanine green by the liver. Schweiz med Wschr, Suppl 105:5–30
Salaspuro MP, Kesaniemi YA (1973) Intravenous galactose elimination test with and without ethanol loading in various clinical conditions. Scand J Gastroent 8:681–686
Schött D, Kuntz HD, Höltmann B, Straub H (1984) Der Einfluß der nasalen Sauerstoffinsufflation auf die Galaktose-Eliminationskapazität der Leber bei Patienten mit chronisch obstruktiver Atemwegserkrankung und respiratorischer Insuffizienz. Atemw Lungenkrkh 10:395–398
Tengström B (1966) An intravenous galactose tolerance test with an enzymatic determination of galactose. A comparison with other diagnostic acids in hepatobiliary diseases. Scand J clin Lab Invest 18, Suppl 92:132–142
Tengström B (1968) An intravenous galactose tolerance test and its use in hepatobiliary diseases. Acta med scand 183:31–40
Tengström B (1969) The discriminatory ability of a galactose tolerance test and some other tests in the diagnosis of cirrhosis of the liver, hepatitis and biliary obstruction. Scand J clin Lab Invest 23:159–168
Tygstrup N, Winkler K (1954) Kinetics of galactose elimination. Acta physiol scand 32:354–362
Tygstrup N, Winkler K (1958) Galactose blood clearancae as a measure of hepatic blood flow. Clin Sci 17:1–9
Tygstrup N (1964a) The galactose elimination capacity in control subjects and in patients with cirrhosis of the liver. Acta med scand 175:281–290
Tygstrup N (1964b) The galactose elimination capacity in relation to clinical and laboratory findings in patients with cirrhosis. Acta med scand 175:291–300
Tygstrup N (1966) Determination of the hepatic elimination capacity of galactose by single injection. Scand J clin Lab Invest 18:118–125
Villeneuve JP (1982) The estimation of hepatic blood blow with indocyanine green: Comparison between the continuous infusion and single injection methods. Amer J Gastroent 77:233–238
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Micklefield, G.H., Schött, D., Kuntz, H.D. et al. Leberfunktion von Patienten mit arterieller Hypoxämie bei chronisch obstruktiver Atemwegserkrankung und der Einfluß der nasalen Sauerstoffinsufflation. Klin Wochenschr 67, 833–838 (1989). https://doi.org/10.1007/BF01725200
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01725200